Cambridge Investment Research Advisors’s DONNELLEY R R & SONS CO DNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-29,702
Closed -$467K 1883
2016
Q3
$467K Buy
29,702
+1,677
+6% +$26.4K 0.01% 1077
2016
Q2
$474K Sell
28,025
-2,517
-8% -$42.6K 0.01% 957
2016
Q1
$501K Sell
30,542
-186
-0.6% -$3.05K 0.01% 898
2015
Q4
$452K Sell
30,728
-1,927
-6% -$28.3K 0.01% 894
2015
Q3
$475K Sell
32,655
-29
-0.1% -$422 0.01% 778
2015
Q2
$570K Buy
32,684
+5,769
+21% +$101K 0.02% 746
2015
Q1
$516K Buy
26,915
+490
+2% +$9.39K 0.01% 783
2014
Q4
$444K Buy
26,425
+1,513
+6% +$25.4K 0.01% 838
2014
Q3
$410K Buy
24,912
+641
+3% +$10.6K 0.01% 924
2014
Q2
$412K Buy
24,271
+1,844
+8% +$31.3K 0.01% 847
2014
Q1
$401K Buy
22,427
+1,179
+6% +$21.1K 0.02% 818
2013
Q4
$431K Buy
21,248
+980
+5% +$19.9K 0.02% 714
2013
Q3
$320K Buy
20,268
+4,450
+28% +$70.3K 0.01% 813
2013
Q2
$222K Buy
+15,818
New +$222K 0.01% 895

Other funds holding DNY

Cambridge Investment Research Advisors's DNY Position: Q4 2016 in Review

Cambridge Investment Research Advisors sold out of DONNELLEY R R & SONS CO (DNY) in Q4 2016, closing a stake of 29,702 shares — an estimated $467K sold.

Cambridge Investment Research Advisors first reported a position in DNY in Q2 2013 and held it in 14 quarters. The position peaked at $570K in Q2 2015. 6 funds tracked by Wall St. Rank hold DNY as of Q4 2016.

  • Cambridge Investment Research Advisors reported no remaining DONNELLEY R R & SONS CO position as of Q4 2016 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 29,702 DONNELLEY R R & SONS CO shares in Q4 2016, an estimated $467K.
  • Cambridge Investment Research Advisors first reported a position in DONNELLEY R R & SONS CO in Q2 2013 and held it in 14 quarters.
  • Cambridge Investment Research Advisors's DONNELLEY R R & SONS CO position peaked at $570K in Q2 2015.
  • 6 funds tracked by Wall St. Rank held DONNELLEY R R & SONS CO as of Q4 2016.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2016, filed 13 Feb 2017.